DIAGNOS INC (DGNOF:OTCMKTS)
$0.1826 -0.005175 (-2.756%)
Analysed DIAGNOS INC (DGNOF:OTCMKTS) News Sources
DIAGNOS Provides an Update on Sales and Regulatory Activities for CARA
08-04-2026
yahoo.com
DIAGNOS Successfully Completes the Renewal of US-FDA Medical Device Establishment Registration
01-04-2026
yahoo.com
DIAGNOS Announces Amendments to Convertible Debentures and Stock Warrants
05-03-2026
yahoo.com
DIAGNOS to present at Centurion One Capital 9th Annual Toronto Growth Conference
24-02-2026
yahoo.com
DIAGNOS and ÉTS Announce $1M+ Federal Investment to Propel Next-Generation Retinal AI Innovation
04-02-2026
yahoo.com
DIAGNOS Announces the Engagement of IBN
15-01-2026
yahoo.com
DIAGNOS Advances Regulatory Strategy for CARA in Key Markets: Updates on Health Canada, FDA, and SFDA Progress
13-01-2026
yahoo.com
DIAGNOS Appoints Dr. Ismail Ben Ayed as Chief Artificial Intelligence (AI) Scientist to Accelerate our Innovation in Healthcare
16-12-2025
yahoo.com
Diagnos Closes $4 Million Private Placement of Units
09-12-2025
yahoo.com
Diagnos Announces Closing of Oversubscribed $4 Million Brokered Private Placement Led by Centurion One Capital
09-12-2025
yahoo.com
What is the current price of DIAGNOS INC (DGNOF:OTCMKTS)?
The current price of DIAGNOS INC (DGNOF:OTCMKTS) is $0.1826.
DIAGNOS INC (DGNOF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of DIAGNOS INC (DGNOF:OTCMKTS) since the previous trading day is $-0.005175.
DIAGNOS INC (DGNOF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of DIAGNOS INC (DGNOF:OTCMKTS) since the previous trading day is -2.756%.
What is the most recent average sentiment score for DIAGNOS INC (DGNOF:OTCMKTS)?
The most recent average sentiment score for DIAGNOS INC (DGNOF:OTCMKTS) is 59 out of 100.
What is the most recent average sentiment for DIAGNOS INC (DGNOF:OTCMKTS)?
The most recent sentiment for DIAGNOS INC (DGNOF:OTCMKTS) is .
SEC-8K** Filing Available For DIAGNOS INC (DGNOF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.